US Patent Issued to Regeneron Pharmaceuticals on June 3 for "Method and system of identifying and quantifying antibody fragmentation" (New York Inventors)

ALEXANDRIA, Va., June 4 -- United States Patent no. 12,320,790, issued on June 3, was assigned to Regeneron Pharmaceuticals Inc. (Tarrytown, N.Y.).

"Method and system of identifying and quantifying antibody fragmentation" was invented by Yuetian Yan (Chappaqua, N.Y.) and Shunhai Wang (Scarsdale, N.Y.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Methods and system for identifying and quantifying antibody fragments and identifying the site of fragmentation on an antibody are provided herein."

The patent was filed on April 23, 2024, under Application No. 18/643,509.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&...